Table-I.
Details of included studies.
| Study ID Location | Procedure Type | Groups | Sample Size | Age (years) | Male (%) | ASA III (%) | Dexmed dose | Comparator drug dose | Rescue drug | Sedation scale |
|---|---|---|---|---|---|---|---|---|---|---|
| Chen 2024 China | Flexible bronchoscopy | Dexmed | 30 | 49 ± 10 | 80 | 6.7 | 0.6 µg/kg loading over 10 min | Remimazolam 0.073 mg/kg or 0.093 mg/kg, respectively for 10 min | Propofol | MOAA/S |
| Control-1 | 29 | 46.6 ± 14.4 | 60 | 3.4 | ||||||
| Control-2 | 30 | 43.3± 15.3 | 76.7 | 3 | ||||||
| Xu 2024 China | Flexible bronchoscopy | Dexmed | 60 | 60.9 ± 4.2 | 68.3 | 0 | 0.5 µg/kg over 10 min + 0.2–0.7 µg/kg/h | Remimazolam 6 mg/kg/h induction + 1–2 mg/kg/h maintenance | Propofol | MOAA/S |
| Control | 60 | 60.7 ± 4.3 | 66.7 | 0 | ||||||
| Zhou 2024 China | Flexible fiberoptic bronchoscopy | Dexmed | 182 | 61 (55–65) | 63.7 | 4.4 | 0.1–0.2 mL/kg loading + 0.1–0.5 mL/kg/h | Remimazolam 0.1–0.2 mL/kg loading + 0.1–0.5 mL/kg/h | Propofol | MOAA/S |
| Control | 182 | 60 (52–66) | 69.2 | 7.7 | ||||||
| Chen 2022 China | Flexible bronchoscopy | Dexmed | 73 | 56.1 ± 6 | 72.6 | NR | 0.5 µg/kg loading over 10 min + 0.2–0.7 µg/kg/h | Remimazolam 12 mg/kg/h induction + 1–2 mg/kg/h maintenance | Propofol | NR |
| Control | 73 | 57.1 ± 5.6 | 75.3 | |||||||
| Pertzov 2022 Israel | Flexible bronchoscopy | Dexmed | 30 | 58.8 ± 15.1 | 43.3 | NR | 1 µg/kg over 15 min + 0.5 µg/kg/h | Propofol 0.5–1 mg/kg induction + 100–200 µg/kg/min infusion | Propofol | Richmond Agitation Sedation Scale |
| Control | 33 | 62.9 ± 9.7 | 69.7 | |||||||
| Chouhan 2023 India | Flexible bronchoscopy | Dexmed | 40 | 52.3 ± 14.3 | 55 | 7.5 | 1 µg/kg over 10 min | Midazolam 0.05 mg/kg Propofol 0.5 mg/kg induction | Propofol | Composite score |
| Control-M | 40 | 58.1 ± 8.3 | 67.5 | 7.5 | ||||||
| Control-P | 40 | 55.6 ± 11.2 | 60 | 12.5 | ||||||
| Kim 2021 Korea | Flexible bronchoscopy | Dexmed | 48 | 63.7 ± 11.3 | 68.8 | NR | 0.25µg/kg loading over 10 min + 0.25-0.75µg/kg/h | Midazolam 0.05 mg/kg loading + 1mg boluses | Midazolam | Ramsay Sedation Scale |
| Control | 54 | 63.9 ± 11.0 | 72.2 | |||||||
| Kumari 2021 India | EBUS-TBNA | Dexmed | 99 | 44 ± 14 | 56.6 | 0 | 1 µg/kg loading + 0.6 µg/kg/h infusion | Midazolam 2 mg bolus | Midazolam | Ramsay Sedation Scale |
| Control | 98 | 49 ± 14 | 51 | |||||||
| Magazine 2021 India | Flexible bronchoscopy | Dexmed | 24 | 48.5 ± 13.1 | 54.2 | NR | 0.75 µg/kg over 10 min | Midazolam 0.035 mg/kg | Midazolam | Ramsay Sedation Scale |
| Control | 24 | 44.4 ± 12.0 | 41.7 | |||||||
| Yuan 2016 China | Flexible bronchoscopy | Dexmed | 50 | 59.8 ± 7.6 | 54 | 30 28 | 1 µg/kg over 10 min + 0.5 µg/kg/h | Propofol (2–4 µg/mL) | Lidocaine | MOAA/S |
| Control | 50 | 60.5 ± 6.9 | 44 | |||||||
| Lin 2020 China | EBUS-TBNA | Dexmed | 25 | 59.7 ± 14.1 | 56 | NR | 1 µg/kg over 10 min + 0.5–1.4 µg/kg/h | Propofol (2.0 µg/mL) | NR | MOAA/S |
| Control | 25 | 59.4 ± 12.2 | 52 | |||||||
| Magazine 2020 India | Flexible bronchoscopy | Dexmed | 27 | 47.1 ± 13.4 | 70.4 | NR | 0.5 µg/kg over 10 min | Midazolam 0.035 mg/kg | Midazolam | Ramsay Sedation Scale |
| Control | 27 | 45 ± 14.3 | 51.9 | |||||||
| Liao 2012 China | Flexible bronchoscopy | Dexmed | 99 | 58.5 ± 9.1 | 61.6 | NR | Up to 1 µg/kg over 10 min + 0.5 µg/kg/h | Midazolam 2 mg bolus + 1 mg titrated | NR | Ramsay Sedation Scale |
| Control | 99 | 60.1 ± 8.4 | 63.3 | |||||||
| Ryu 2012 Korea | Flexible bronchoscopy | Dexmed | 35 | 52.9 ± NR | 57 | NR | Infusion 1.0 ± 0.4 µg/kg/min | Remifentanil infusion | Airway maneuvers only | MOAA/S |
| Control | 35 | 52.9 ± NR | 51 | |||||||
| Goneppanavar 2015 India | Flexible bronchoscopy | Dexmed | 27 | 49.7 ± 13.9 | 74.1 | NR | 1 µg/kg over 10 min (single bolus) | Midazolam 0.02 mg/kg | Midazolam | Ramsay Sedation Scale |
| Control | 27 | 52.5 ± 15.1 | 88.9 | |||||||
| Riachy 2017 Lebanon | Flexible bronchoscopy | Dexmed | 53 | NR | 58.5 | NR | 0.5 µg/kg over 10 min + lidocaine | Alfentanil 10 µg/kg bolus + lidocaine | Midazolam | Nursing Instrument for the Communication of Sedation score |
| Control | 55 | 43.6 | ||||||||
| Zhang 2021 China | Flexible bronchoscopy | Dexmed | 222 | 58 ± 14 | 62.6 | NR | 1 µg/kg (max 50 µg) + midazolam | Fentanyl 1 µg/kg (max 50 µg) + midazolam | Midazolam | Bispectral index |
| Control | 211 | 60.2 ± 11.6 | 59.7 |
NR, not reported; ASA, American Society of Anesthesiologist; max, maximum; IV, intravenous; MOAA/S, Modified Observer’s Assessment of Alertness/Sedation; Dexmed, Dexmedetomidine; EBUS-TBNA, endobronchial ultrasound–guided transbronchial needle aspiration.